Is Smith & Nephew plc a good dividend stock?

Smith & Nephew plc (SNN) is a dividend-paying stock with a current dividend yield of 4.14%. Review its dividend history, payout consistency and growth to judge whether it fits your income strategy.

What is SNN's dividend yield?

The dividend yield for SNN stock is currently 4.14%.

How much does SNN pay in dividends per year?

Smith & Nephew plc pays an annual dividend of $1.0940 per share over the trailing twelve months.

How often does SNN pay dividends?

SNN stock pays dividends bi-annually.

Is SNN's dividend growing?

Smith & Nephew plc's 3-year dividend CAGR is 1.86%.

SNN Stock Price, Chart, Stats & News

Smith & Nephew plc

Save

Overview Dividend safety Dividends Fundamentals

Smith & Nephew plc (SNN) is a dividend-paying stock with a current dividend yield of 4.14% as of Oct 2, 2026. It pays $1.09 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a 1.11% 5-year compound annual rate.

11.09B

Market cap

17.84x

Current P/E

11.16x

Forward P/E

4.14%

Dividend yield

$1.09

SNN dividend

Dividend safety

Moderate

Dividend coverage is moderate for SNN — it pays out about 74% of earnings.

See the safety analysis

SNN chart

Fundamentals

Gross margin	68.01%
Operating margin	16.27%
Pretax margin	12.64%
Net margin	10.14%
Effective tax rate	19.77%
ROA	5.99%
ROE	11.58%
D/E	0.63x
Interest coverage ratio	6.43x

All financials

SNN valuation

P/E	17.84x
P/S	2.18x
P/B	2.59x
P/CF	10.65x
P/FCF	15.76x
P/OCF	10.65x
PEG	0.78x
EV multiple	6.77x

About

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.